27.04.24 | Vollzeit | | Vereinigtes Königreich | Acorn by SynergieSpecialist Anti-Cancer Treatment Pathway Coordinator To be considered for an interview, please make sure your application is full in line with the job specs as found below. NHS Cheltenham Monday to Friday 9am - 5pm Permanent Up to £25,000 Based on experience We are currently supporting the NHS
Später ansehen26.04.24 | Vollzeit | Köln | Miltenyi Biotec B.V. & Co. KGTheir accessibility to patients worldwide with the goal of improving and prolonging patients' lives. We are currently focusing on difficult-to-treat hematological cancers using CAR-T and other technologies, while also exploring treatments for other diseases. Our lead candidate, currently in pivotal clinical trials
Später ansehen26.04.24 | Vollzeit | Augsburg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen26.04.24 | Vollzeit | Bergisch Gladbach | Miltenyi Biotec B.V. & Co. KGTheir accessibility to patients worldwide with the goal of improving and prolonging patients' lives. We are currently focusing on difficult-to-treat hematological cancers using CAR-T and other technologies, while also exploring treatments for other diseases. Our lead candidate, currently in pivotal clinical trials
Später ansehen26.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen26.04.24 | Vollzeit | Wuppertal | Miltenyi Biotec B.V. & Co. KGTheir accessibility to patients worldwide with the goal of improving and prolonging patients' lives. We are currently focusing on difficult-to-treat hematological cancers using CAR-T and other technologies, while also exploring treatments for other diseases. Our lead candidate, currently in pivotal clinical trials
Später ansehen26.04.24 | Vollzeit | Köln | Miltenyi Biotec B.V. & Co. KGTheir accessibility to patients worldwide with the goal of improving and prolonging patients' lives. We are currently focusing on difficult-to-treat hematological cancers using CAR-T and other technologies, while also exploring treatments for other diseases. Our lead candidate, currently in pivotal clinical trials
Später ansehen25.04.24 | Studentenjobs, Vollzeit | Jena | Universitätsklinikum JenaThe successful candidate will contribute to our ongoing research project funded by the DFG focusing on developing mRNA-based therapeutic strategies of colitis ulcerosa. This is an exciting opportunity to work on a project that aims to advance diagnosis, treatment, and patient care for individuals
Später ansehen26.04.24 | Vollzeit | Garching bei München | ITM Isotope Technologies Munich SEAnd growing pipeline of targeted treatments in various stages of clinical development addressing cancers . click apply for full job details
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Cancer Treatment in Deutschland kostenlos abonnieren.